Company Description
NeuroPace, Inc. operates as a medical device company in the United States.
The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy.
It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.
Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.
The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures.
NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
| Country | United States |
| Founded | 1997 |
| IPO Date | Apr 22, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 171 |
| CEO | Joel Becker |
Contact Details
Address: 455 North Bernardo Avenue Mountain View, California 94043 United States | |
| Phone | 650 237 2700 |
| Website | neuropace.com |
Stock Details
| Ticker Symbol | NPCE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001528287 |
| CUSIP Number | 641288105 |
| ISIN Number | US6412881053 |
| Employer ID | 22-3550230 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joel D. Becker | Chief Executive Officer, President and Director |
| Rebecca L. Kuhn | Chief Financial Officer, Vice President of Finance and Administration, Corporate Secretary and Assistant Secretary |
| Dr. Martha J. Morrell | Chief Medical Officer |
| Dylan St. John | Chief of Operations and Development |
| Leah Akin | Acting General Counsel |
| Kelley Nicholas | Vice President of Sales |
| Amy Treadwell | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 4, 2024 | SCHEDULE 13G | Filing |
| Oct 28, 2024 | 144 | Filing |
| Oct 3, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 3, 2024 | 144 | Filing |
| Aug 13, 2024 | 10-Q | Quarterly Report |
| Aug 13, 2024 | 8-K | Current Report |